Narrow Results

Hospitals' Community Benefits.

The Question of Fair Benefits in International Research.

Access to Medicines and Corporate Social Responsibilities of the Pharmaceutical Industry.

Corporate Social Responsibility of the Pharmaceutical Industry in Solidaristic Terms.

Reflections on a “Systems Approach” to Medicines in Health Systems.

The Case for Rarity.

Singapore's Approach to the Challenge of High-Cost Medical Interventions.

Universal Health Coverage and the Social Value of Drug Development.

ATOZET® a New Combination Treatment Option for High-Risk Patients to Lower LDL Cholesterol, is Now Approved in Singapore.

ASEAN+ Rare Disease Network Established.

Luye Medical Joins Forces with OncoCare To Expand Its Integrated Healthcare Services Platform for Their Patients.

NUS Pharmacy Team Develops Online “Calculator” to Predict Risk of Early Hospital Readmission.

The Bare Essentials: Ensuring Affordable Access to Insulin.

AstraZeneca’s CVD-REAL Study Shows SGLT-2 Inhibitors Significantly Reduced Death and Hospitalisations for Heart Failure Versus Other Type-2 Diabetes Medicines.

Now growing at a rate of over 5% per annum, the $3 billion ‘alternative health therapies’ business is now positioned in the top ten growth industries in Australia. With poor regulation of both therapeutic goods and the unregistered therapists who promote them, cancer patients may well be putting their health at risk when they place their faith in many so-called ‘natural’ or ‘traditional’ treatments. With a focus on what complementary therapists refer to as ‘energy medicine’ and ‘nutritional medicine’, this chapter explores the risks and benefits of some of the more popular alternative health-care choices. While investigating their histories, it outlines what influences cancer patients to try these unproven therapies, and the conflict and contrast in information relating to the claims made for them and the conclusions of evidence-based research. Although there are a number of complementary therapies that are of benefit to some patients, both during and after their cancer treatments, ‘natural’ does not always equal ‘safe’, may be expensive and may even compromise their health. More patients now want a greater say in their choices of treatment, and selecting complementary therapies that may help is another of the many challenges faced in trying to make informed choices, as we navigate along our individual roads on our journeys to recovery.